NCT00534534已完成不适用
Randomized Clinical Trial of the Effect of Standard Versus Intensive Intervention Protocol in Attempting to Reduce Recurrent Episodes of Acute Alcoholic Pancreatitis
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 120
- 试验地点
- 2
- 主要终点
- The number of recurrent pancreatitis during the study period
研究概览
简要总结
Retrospective studies have shown, that about half of the patients will have a recurrent episode after the first acute alcoholic pancreatitis. Of the patients in hospital, more than half annually are treated for recurrent acute pancreatitis. Because alcohol has been shown an important factor in the development of recurrent pancreatitis, it was hypothesized, that by attempting intensively to diminish the individual alcohol consumption the number of recurrent pancreatitis could be decreased. Two protocols will be compared: A) initial intervention against alcohol abuse and B) repeated interventions at 6 month intervals.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who recovered from their first acute alcoholic pancreatitis and start to be ready to be discharged from hospital
排除标准
- •Other etiologies of pancreatitis besides alcohol
- •Uncertain diagnosis
- •Recurrent disease
结局指标
主要结局
The number of recurrent pancreatitis during the study period
时间窗: 2 years
次要结局
- Decrease of alcohol consumption(2 years)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Clinical Relapse Prediction of Ulcerative Colitis Using an Endoscopy Automated Diagnosis Systemulcerative colitisJPRN-UMIN000036650Digestive Disease Center,Showa University Northern Yokohama Hospital150
已完成
2 期
Velcade™ (bortezomib) combination chemotherapy in AL amyloidosisCancerISRCTN33283585niversity College London (UCL) (UK)52
终止
4 期
Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMSRelapsing Remitting Multiple SclerosisNCT00202995Teva Branded Pharmaceutical Products R&D, Inc.91
招募中
不适用
A prospective, observational study for outcomes and safety profiles of MRI-guided transurethral ultrasound ablation of the prostate for prostate cancerprostate cancerJPRN-UMIN000038291Sapporo Hokuyu Hospital30
已完成
不适用
Real-world Outcomes on Tecfidera (BG00012, Dimethyl Fumarate) Post-Tysabri (BG00002, Natalizumab)Relapsing-Remitting Multiple SclerosisNCT02159573Biogen530
